MERRI EARL: Open Payments
NPI 1437573938 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 24 payments from 12 companies in 2025. Trend: 2023 $697 · 2024 $517 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $107 |
| ABBVIE INC. | 4 | $73 |
| Abbott Laboratories | 4 | $70 |
| Lilly USA, LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: FREESTYLE LIBRE 3, Ozempic, VRAYLAR, Rybelsus, MOUNJARO, Cologuard Collection Kit, INJECTAFER, INSPIRE.
Industry payments across AL — which companies pay providers there.
